首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.
【24h】

The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.

机译:HIT专家概率(HEP)评分:一种基于广泛专家意见的肝素诱导的血小板减少症的新型预测试概率模型。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The diagnosis of heparin-induced thrombocytopenia (HIT) is challenging. Over-diagnosis and over-treatment are common. OBJECTIVES: To develop a pre-test clinical scoring model for HIT based on broad expert opinion that may be useful in guiding clinical decisions regarding therapy. PATIENTS/METHODS: A pre-test model, the HIT Expert Probability (HEP) Score, was constructed based on the opinions of 26 HIT experts. Fifty patients referred to a reference laboratory for HIT testing comprised the validation cohort. Two hematology trainees scored each patient using the HEP Score and a previously published clinical scoring system (4 T's). A panel of three independent experts adjudicated the 50 patients and rendered a diagnosis of HIT likely or unlikely. All subjects underwent HIT laboratory testing with a polyspecific HIT ELISA and serotonin release assay (SRA). RESULTS: The HEP Score exhibited significantly greater interobserver agreement [intraclass correlation coefficient: 0.88 (95% CI 0.80-0.93) vs. 0.71 (0.54-0.83)], correlation with the results of HIT laboratory testing and concordance with the diagnosis of the expert panel (area under receiver-operating curve: 0.91 vs. 0.74, P = 0.017) than the 4 T's. The model was 100% sensitive and 60% specific for determining the presence of HIT as defined by the expert panel and would have allowed for a 41% reduction in the number of patients receiving a direct thrombin inhibitor (DTI). CONCLUSION: The HEP Score is the first pre-test clinical scoring model for HIT based on broad expert opinion, exhibited favorable operating characteristics and may permit clinicians to confidently reduce use of alternative anticoagulants. Prospective multicenter validation is warranted.
机译:背景:肝素诱导的血小板减少症(HIT)的诊断具有挑战性。过度诊断和过度治疗很常见。目的:基于广泛的专家意见,开发一种针对HIT的测试前临床评分模型,这可能对指导有关治疗的临床决策很有用。患者/方法:基于26位HIT专家的意见,构建了预测试模型HIT专家概率(HEP)分数。共有50名患者转诊至参考实验室进行HIT测试。两名血液学受训者使用HEP评分和先前发布的临床评分系统(4个T)对每个患者评分。由三名独立专家组成的小组对这50名患者进行了裁决,并可能或不太可能诊断出HIT。所有受试者均接受了HIT实验室测试,包括多特异性HIT ELISA和血清素释放测定(SRA)。结果:HEP评分显示出更大的观察者间一致性[组内相关系数:0.88(95%CI 0.80-0.93)vs. 0.71(0.54-0.83)],与HIT实验室测试的结果相关,并且与专家的诊断一致面板(接收器工作曲线下的面积:0.91对0.74,P = 0.017)比4 T高。根据专家小组的定义,该模型对确定HIT的存在具有100%的敏感性和60%的特异性,并且可以使接受直接凝血酶抑制剂(DTI)的患者人数减少41%。结论:HEP评分是基于广泛专家意见的首个HIT的临床前临床评分模型,具有良好的操作特性,可能使临床医生放心地减少使用其他抗凝剂的可能性。保证进行前瞻性多中心验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号